These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 17512576

  • 1. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
    Yu J, Qian H, Li Y, Wang Y, Zhang X, Liang X, Fu M, Lin C.
    Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J, Wang B.
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
    Wei LH, Lai KP, Chen CA, Cheng CH, Huang YJ, Chou CH, Kuo ML, Hsieh CY.
    Oncogene; 2005 Jan 13; 24(3):390-8. PubMed ID: 15531921
    [Abstract] [Full Text] [Related]

  • 4. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS, Song PL, Sun B, Jiang HC, Liu TF.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 13; 8(5):510-7. PubMed ID: 19822495
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
    Park MJ, Lee JY, Kwak HJ, Park CM, Lee HC, Woo SH, Jin HO, Han CJ, An S, Lee SH, Chung HY, Park IC, Hong SI, Rhee CH.
    J Cell Biochem; 2005 Aug 01; 95(5):955-69. PubMed ID: 15962302
    [Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW, Chen MW, Chiu CF, Hong CC, Cheng CC, Hsiao M, Chen CA, Wei LH, Su JL.
    Ann Surg Oncol; 2014 Dec 01; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [Abstract] [Full Text] [Related]

  • 7. Involvement of matrix metalloproteinases in the inhibition of cell invasion and migration through the inhibition of NF-[kappa]B by the new synthesized ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOTO1007) in human cervical cancer Ca ski cells.
    Huang AC, Hsu SC, Kuo CL, Liao CL, Lai KC, Lin TP, Wu SH, Lu HF, Tang NY, Yang JS, Chung JG.
    In Vivo; 2009 Dec 01; 23(4):613-9. PubMed ID: 19567397
    [Abstract] [Full Text] [Related]

  • 8. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
    Wang X, Wang G, Dong D, Fu S, Yang B.
    Exp Toxicol Pathol; 2008 Sep 01; 60(6):481-8. PubMed ID: 18606528
    [Abstract] [Full Text] [Related]

  • 9. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
    Kim A, Kim MJ, Yang Y, Kim JW, Yeom YI, Lim JS.
    Carcinogenesis; 2009 Jun 01; 30(6):927-36. PubMed ID: 19336468
    [Abstract] [Full Text] [Related]

  • 10. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S, Fernández R, Güézmes A, Sánchez-Barceló EJ.
    Cancer Res; 1998 Oct 01; 58(19):4383-90. PubMed ID: 9766668
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Bcl-2 partly inhibits apoptosis of human cervical cancer SiHa cells induced by arsenic trioxide.
    Deng Y, Lin C, Zheng J, Fu M, Liang X, Chen J, Xiao P, Wu M.
    Chin Med J (Engl); 2000 Jan 01; 113(1):84-8. PubMed ID: 11775218
    [Abstract] [Full Text] [Related]

  • 12. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U, Terry NH, Kala SV, Lieberman MW, Story MD.
    Cancer Chemother Pharmacol; 2005 Jun 01; 55(6):511-21. PubMed ID: 15761769
    [Abstract] [Full Text] [Related]

  • 13. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
    Song Y, Zhang C.
    Cancer Chemother Pharmacol; 2009 Mar 01; 63(4):605-13. PubMed ID: 18521605
    [Abstract] [Full Text] [Related]

  • 14. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
    Wen X, Li D, Zhang Y, Liu S, Ghali L, Iles RK.
    Anticancer Drugs; 2012 Mar 01; 23(3):280-7. PubMed ID: 22245994
    [Abstract] [Full Text] [Related]

  • 15. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
    Cunha De Santis G, Tamarozzi MB, Sousa RB, Moreno SE, Secco D, Garcia AB, Lima AS, Faccioli LH, Falcão RP, Cunha FQ, Rego EM.
    Haematologica; 2007 Dec 01; 92(12):1615-22. PubMed ID: 18055984
    [Abstract] [Full Text] [Related]

  • 16. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH, Zhao M, Liu J, Wei Y, Wu XX.
    Ai Zheng; 2006 Jul 01; 25(7):811-7. PubMed ID: 16831269
    [Abstract] [Full Text] [Related]

  • 17. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW.
    Gynecol Oncol; 2009 Mar 01; 112(3):646-53. PubMed ID: 19095296
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway.
    Liu Y, Zhang W, Zhang X, Qi Y, Huang D, Zhang Y.
    Exp Biol Med (Maywood); 2011 May 01; 236(5):592-7. PubMed ID: 21540248
    [Abstract] [Full Text] [Related]

  • 19. Role of alphavbeta3 integrin receptor in the invasive potential of human cervical cancer (SiHa) cells.
    Chatterjee N, Chatterjee A.
    J Environ Pathol Toxicol Oncol; 2001 May 01; 20(3):211-21. PubMed ID: 11797830
    [Abstract] [Full Text] [Related]

  • 20. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro.
    Bellyei S, Schally AV, Zarandi M, Varga JL, Vidaurre I, Pozsgai E.
    Cancer Lett; 2010 Jul 01; 293(1):31-40. PubMed ID: 20064686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.